Illumina Signs Agreement to Acquire GenoLogics
August 4, 2015
San Diego, CA — Illumina, Inc. (NASDAQ: ILMN) today announced it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations. The acquisition strengthens the industry-leading portfolio of Illumina genetic analysis solutions.
“The acquisition of GenoLogics demonstrates Illumina’s
Author: GenoLogics and Illumina
